-
1
-
-
0015337140
-
Disseminated intravascular coagulation (DIC); An approach
-
Colman RT, Robboy SJ, Minna ID: Disseminated intravascular coagulation (DIC); An approach. Am J Med 52:679-689, 1974.
-
(1974)
Am J Med
, vol.52
, pp. 679-689
-
-
Colman, R.T.1
Robboy, S.J.2
Minna, I.D.3
-
2
-
-
0015293025
-
Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia
-
Gralnick HR, Bargrey J, Abrell E: Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Am J Med 52:167-174, 1972.
-
(1972)
Am J Med
, vol.52
, pp. 167-174
-
-
Gralnick, H.R.1
Bargrey, J.2
Abrell, E.3
-
3
-
-
0023828836
-
Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
-
Pelzer H, Schwarz A, Heinburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59:101-106, 1987.
-
(1987)
Thromb Haemost
, vol.59
, pp. 101-106
-
-
Pelzer, H.1
Schwarz, A.2
Heinburger, N.3
-
4
-
-
0023093671
-
Monoclonal antibodies to discrete regions in α2-plasmin inhibitor
-
Mimuro J, Koike Y, Sumi Y, Aoki N: Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 69:446-453, 1987.
-
(1987)
Blood
, vol.69
, pp. 446-453
-
-
Mimuro, J.1
Koike, Y.2
Sumi, Y.3
Aoki, N.4
-
5
-
-
0021084637
-
Am immunoassay for human D-dimer using monoclonal antibodies
-
Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG: Am immunoassay for human D-dimer using monoclonal antibodies. Thromb Res, 31:767-778, 1983.
-
(1983)
Thromb Res
, vol.31
, pp. 767-778
-
-
Rylatt, D.B.1
Blake, A.S.2
Cottis, L.E.3
Massingham, D.A.4
Fletcher, W.A.5
Masci, P.P.6
Whitaker, A.N.7
Elms, M.8
Bunce, I.9
Webber, A.J.10
Wyatt, D.11
Bundesen, P.G.12
-
6
-
-
0013993406
-
Gelation of soluble fibrin in plasma by ethanol
-
Godal HC, Abildgarred U: Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 3:343-350, 1966.
-
(1966)
Scand J Haematol
, vol.3
, pp. 343-350
-
-
Godal, H.C.1
Abildgarred, U.2
-
7
-
-
84942489183
-
Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation
-
Weiding JU, Eisinger G, Kostering H: Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation. J Clin Chem Clin Biochem, 27:57-64, 1989.
-
(1989)
J Clin Chem Clin Biochem
, vol.27
, pp. 57-64
-
-
Weiding, J.U.1
Eisinger, G.2
Kostering, H.3
-
8
-
-
0017073209
-
Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers
-
Largo R, Heller V, Straub PW: Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers. Blood 47:991-1002, 1976.
-
(1976)
Blood
, vol.47
, pp. 991-1002
-
-
Largo, R.1
Heller, V.2
Straub, P.W.3
-
9
-
-
0022545605
-
Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay
-
Wiman B, Ranby M: Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 55:189-193, 1986.
-
(1986)
Thromb Haemost
, vol.55
, pp. 189-193
-
-
Wiman, B.1
Ranby, M.2
-
10
-
-
0027475513
-
A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo
-
Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, Draeger B, Naser W, Dessauer A: A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinol 4:97-102, 1993.
-
(1993)
Blood Coagul Fibrinol
, vol.4
, pp. 97-102
-
-
Lill, H.1
Spannagl, M.2
Trauner, A.3
Schramm, W.4
Schuller, D.5
Ofenloch-Haehnle, B.6
Draeger, B.7
Naser, W.8
Dessauer, A.9
-
11
-
-
0021087622
-
Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DlC in Japan
-
Kobayashi N, Maegawa T, Takada M, Tanaka H, Gonmori H: Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DlC in Japan. Bibl Haematol 49:265-275, 1987.
-
(1987)
Bibl Haematol
, vol.49
, pp. 265-275
-
-
Kobayashi, N.1
Maegawa, T.2
Takada, M.3
Tanaka, H.4
Gonmori, H.5
-
12
-
-
0027312189
-
Hemostatic study before onset of disseminated intravascular coagulation
-
Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi A, Mori Y, Deguchi K, Shirakawa S, Suzuki K: Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43:190-194, 1994.
-
(1994)
Am J Hematol
, vol.43
, pp. 190-194
-
-
Wada, H.1
Minamikawa, K.2
Wakita, Y.3
Nakase, T.4
Kaneko, T.5
Ohiwa, M.6
Tamaki, S.7
Deguchi, A.8
Mori, Y.9
Deguchi, K.10
Shirakawa, S.11
Suzuki, K.12
-
13
-
-
0019136967
-
FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. I. Inhibition of thrombin and factor Xa in vitro
-
Ohno H, Kosaki G, Kambayashi J, Imaoka S, Hirata F: FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. I. Inhibition of thrombin and factor Xa in vitro. Thromb Res 19:579-588, 1980.
-
(1980)
Thromb Res
, vol.19
, pp. 579-588
-
-
Ohno, H.1
Kosaki, G.2
Kambayashi, J.3
Imaoka, S.4
Hirata, F.5
-
14
-
-
0019832631
-
FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. II. in vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin
-
Ohno H, Kambayashi J, Chang SW, Kosaki G: FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thromb Res 24:445-452, 1981.
-
(1981)
Thromb Res
, vol.24
, pp. 445-452
-
-
Ohno, H.1
Kambayashi, J.2
Chang, S.W.3
Kosaki, G.4
-
15
-
-
0023876972
-
Anticoagulant activity in cell homogenate of adult T cell leukemia
-
Wada H, Tomeoku M, Deguchi A, Suzuki H, Mori Y, Ito M, Deguchi K, Shirakawa S: Anticoagulant activity in cell homogenate of adult T cell leukemia. Thomb Haemost 59:197-201, 1988.
-
(1988)
Thomb Haemost
, vol.59
, pp. 197-201
-
-
Wada, H.1
Tomeoku, M.2
Deguchi, A.3
Suzuki, H.4
Mori, Y.5
Ito, M.6
Deguchi, K.7
Shirakawa, S.8
-
16
-
-
0023211715
-
Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism
-
Goldstein BJ, Mushlin AI: Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 2:20-24, 1987.
-
(1987)
J Gen Intern Med
, vol.2
, pp. 20-24
-
-
Goldstein, B.J.1
Mushlin, A.I.2
-
17
-
-
0027497737
-
Soluble fibrin as molecular marker for a pre-thrombotic state. A mini-review
-
Nieuwenhuizen W: Soluble fibrin as molecular marker for a pre-thrombotic state. A mini-review. Blood Coag Fibrinol 4:93-96, 1993.
-
(1993)
Blood Coag Fibrinol
, vol.4
, pp. 93-96
-
-
Nieuwenhuizen, W.1
-
18
-
-
0027396048
-
Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay
-
Spannagl M, Trauner A, Birg A, Frank G, Hoffmann H, Siebeck M, Lill H: Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay. Blood Coagul Fibrinol 4:103-106, 1993.
-
(1993)
Blood Coagul Fibrinol
, vol.4
, pp. 103-106
-
-
Spannagl, M.1
Trauner, A.2
Birg, A.3
Frank, G.4
Hoffmann, H.5
Siebeck, M.6
Lill, H.7
-
19
-
-
9244223369
-
Monitoring the anticoagulant treatment of DIC and recurrent thrombosis in patients with malignancies using the measurement of "soluble fibrin" (FM-test, Chromogenix), F1 + 2 and TAT complexes
-
Muller-Berghaus et al. (eds): Amsterdam: Elsevier Science Publishers B.V.
-
Stibbe J: Monitoring the anticoagulant treatment of DIC and recurrent thrombosis in patients with malignancies using the measurement of "soluble fibrin" (FM-test, Chromogenix), F1 + 2 and TAT complexes. In Muller-Berghaus et al. (eds): "DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation." Amsterdam: Elsevier Science Publishers B.V., 1993, p 113.
-
(1993)
DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation
, pp. 113
-
-
Stibbe, J.1
-
20
-
-
9244222836
-
Determination of plasma fibrin monomers by a newly developed ELISA method in patients with disseminated intravascular coagulation
-
Muller-Berghaus (ed): Amsterdam: Elsevier Science Publishers B.V.
-
Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K: Determination of plasma fibrin monomers by a newly developed ELISA method in patients with disseminated intravascular coagulation. In Muller-Berghaus (ed): "DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation." Amsterdam: Elsevier Science Publishers B.V., 1993, p 113.
-
(1993)
DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation
, pp. 113
-
-
Okajima, K.1
Uchiba, M.2
Murakami, K.3
Okabe, H.4
Takatsuki, K.5
-
21
-
-
0029082904
-
Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun
-
Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H, the Mie DIC Study Group: Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 74:848, 1996.
-
(1996)
Thromb Haemost
, vol.74
, pp. 848
-
-
Wada, H.1
Wakita, Y.2
Nakase, T.3
Shimura, M.4
Hiyoyama, K.5
Nagaya, S.6
Mori, Y.7
Shiku, H.8
|